StonvexLoading…
StonvexStonvexStonvexCore line items from GHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|---|
Revenue | $1.30B | $4.91B | $3.66B | $2.38B | $1.17B |
Operating Income | Not available | $234.95M | $187.36M | $120.22M | $47.47M |
Net Income | Not available | $292.29M | $183.57M | $60.64M | $23.89M |
EPS (Diluted) | $15.05 | $66.47 | $41.75 | $13.81 | $5.45 |
Total Assets | Not available | $8.40B | $7.85B | $7.62B | $7.62B |
Total Liabilities | Not available | $3.53B | $3.31B | $3.18B | $3.25B |
Cash & Equivalents | Not available | $266.99M | $190.82M | $176.22M | $156.70M |
Free Cash Flow OCF − CapEx | Not available | $275.30M | $270.28M | $108.53M | $30.53M |
Shares Outstanding | Not available | 4.37M | 4.37M | 4.37M | 4.36M |